Testing Services Targeting To Preclinical Studies Suppliers Serving Australasia

iMouse GmbH, a Berlin-based company specializing in digital home cage monitoring solutions for preclinical research. Their flagship product, the iMouse system, aims to enhance objectivity, reduce human bias, and improve animal welfare in laboratory ...

Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...

INNOPROOF GmbH - Your independent, award-winning laboratory for accredited testing of implants and surgical instruments. We are accredited by ISO 17025:2018 standards and our test reports are accepted globally by MRA-ILAC recognition. From the ...

Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite their drug candidates to market. Regis has the technical and operational capabilities to fully support our clients' preclinical and clinical API ...

We, ROKIT Healthcare, endeavor and strive to change the world with our customized artificial organ platforms. We want to provide the safest and effective organ regeneration platform services with our expertise in regenerative medicine. I believe ...

Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...

Fivephoton Biochemicals specializes in the manufacturing and commercialization of convenient to use research tools for the biological, chemical and pharmaceutical research community. We offer innovative research solutions for the demands of a global ...

Diagnosys is an inventor-owned private company devoted to the field of ophthalmic electrophysiology. Founded in 1983 as Doran Instruments, this company invented the Maculoscope, a focal ERG system that is the predicate device for most of the ...

U.S. Stem Cell, Inc. (OTC:USRM) is an emerging leader in the worldwide development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Based in Sunrise, Florida, the Company has developed a clinical ...

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and ...

ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT and other gene editing technologies developed after 12 ...

CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in ...

EnColl Corporation, established in 1994, is a California corporation that develops, manufactures and markets Type-I collagen-based products. EnColl uses its patented technology for the preparation of high purity and charge modified collagen (U.S. ...

IntraOp is the leading innovator of electron therapy devices for treating cancer. IntraOp’s compact and mobile linear accelerators enable oncologists to deliver effective, precise, and affordable radiation therapy at the point of care. The Mobetron ...

Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking science into medicines that ...

We design, develop, manufacture and assemble components, semi-finished products, and final devices for Interventional Radiology and Cardiology using proprietary know-how and technologies. Founded and based in Barcelona by a team of more than 60 ...

Alesi Surgical was founded in 2009 to develop and commercialise products that improve the safety, efficacy and outcomes of surgical procedures. The company is a spin-out from the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical ...

KiOmed Pharma, based in Belgium, is a biotech company that focuses on the development, manufacture and distribution of safe and effective medical devices based on KiOmedine CM-Chitosan, our innovative and exclusive animal-free bioresorbable ...

Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical ...

Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...